Pink & Teal | Evaluation Questionnaire P&T | Evaluation Questionnaire How likely are you to recommend this course to a friend or colleague? * 1 2 3 4 5 (1-Not Likely to 5-Very Likely) I attest that I have completed this educational activity in its entirety. * Yes No Were faculty disclosures made prior to the start of the CME activity? * Yes No Since completing the CME activity, please rate whether the following educational objectives were met. Describe the evolving gene mutational spectrum of malignant breast and ovarian cancers as well as the genetic implications of these diseases. * Agree Disagree Neutral List the advances in biologic knowledge and treatments, including hormonal, chemotherapeutic, and targeted based treatments for breast and ovarian cancers. * Agree Disagree Neutral Discuss the shift in knowledge and treatment decision making in breast and ovarian cancers. * Agree Disagree Neutral Explain the current knowledge on hematologic complications of COVID-19 and the impact of vaccines on the treatment, efficacy, and health of patients being treated for these malignancies. * Agree Disagree Neutral Please rate the projected impact of this activity on your knowledge, competence, performance, and patient outcomes: This activity increased my knowledge. * Yes No No Change This activity increased my competence. * Yes No No Change This activity increased my performance. * Yes No No Change This activity increased my patient outcomes. * Yes No No Change Do you feel the activity was scientifically sound and free of commercial bias or influence? * Yes No Comments Please identify how you will change your practice as a result of attending this activity. This activity validated my current practice. No changes will be made. * Yes No Create/revise protocols, policies, and/or procedures * Yes No Change the management and/or treatment of my patients * Yes No Other Please indicate any barriers you perceive in implementing these changes. * Cost Lack of experience Lack of opportunity (patients) Lack of resources (equipment) Lack of administrative support Lack of time to assess/counsel patients Patient compliance issues Lack of consensus or professional guidelines No barriers OtherOther Will you attempt to address these barriers in order to implement changes in your competence, performance, and/or patients' outcomes? * Yes No NA The content of this activity matched my current (or potential) scope of practice * Yes No Please rate the following faculty: Dr. Judy Garber (DFCI) – Genetic Testing Comes of Age in Breast and Ovarian Cancer Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments Dr. Tiffany Traina (MSKCC) – Triple Negative Breast Cancer: Have we made any progress? Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments Dr. Sudhir Gupta (UCI) – COVID-19 and Cancer: Virus to Vaccine Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments Dr. William Audeh (Agendia) - The Long and Winding Road of PARP Inhibitor Development Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments Dr. Mark Robson (MSKCC) - Managing Patients with Moderate Penetrance Mutations Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments Dr. Maria Theodoulou (NYOH) - The Clinical Seasons of HER-2 neu Positive Breast Cancer Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments Dr. Chau Dang (MSKCC) - Updates in the Treatment of HER-2 Positive Breast Cancer Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments Dr. Claudine Isaacs (GU) - Updates on Endocrine Therapy in Early Stage Breast Cancer Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments Dr. Leslie Boyd (NYU Langone) - Therapeutic HPV Vaccines: On the Horizon Speaker was knowledgeable regarding the content * Agree Disagree Neutral NA Presentations were balanced, objective, and scientifically rigorous * Agree Disagree Neutral NA Speaker's presentation and teaching skills were effective * Agree Disagree Neutral NA Comments What is your overall evaluation of this CME activity? * Excellent Very Good Fair Poor Describe any presentations that did not meet your needs or expectations. Please share any suggestions for future topics. reCAPTCHA Submit